Doctors Without Borders is closing its widely regarded access-to-medicines campaign

Taking stock of the drug industry, from the lab to the medicine chest

June 20, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Doctors Without Borders is closing its widely regarded access-to-medicines campaign "It is a shocking blow, because the access campaign is a cornerstone of the wider access to medicines movement," said one expert. By Ed Silverman STAT+ | Gilead's twice-yearly antiviral protected women from HIV infection in large trial If confirmed in a second study, the data could set up lenacapavir to be approved as an option for pre-exposure prophylaxis, or PrEP, for HIV. By Jason Mast STAT+ | New study bolsters evidence rare genetic mutation can delay early Alzheimer's The paper is the latest example of researchers refining their understanding of Alzheimer's by studying an extended family with about 6,000 living members. By Jonathan Wosen STAT+ | A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals The results of HELIOS-B will also impact competitors, including BridgeBio Pharma and Ionis Pharmaceuticals. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser